The overall inferences from the study are that lack of Lrp5 function i) has no influence on the amount of disuse-related bone loss in cortical bone but is associated with greater bone loss in cancellous Small molecule library bone; and ii) prevents load-induced bone formation in the cortex and inhibits the response in trabecular bone in male mice. It is difficult

to conclude whether Lrp5 status had similar effects in female mice since for most parameters, neither the female Lrp5−/− mice nor their WT+/+ littermate controls showed a significant dose:response to loading. In contrast, the presence of the Lrp5 G171V HBM mutation in both males and females was associated with some protection against disuse-related

bone loss in both cortical and cancellous bone and an increased osteogenic responsiveness to loading that was especially apparent in the females. The rationale for examining the bone loss associated with disuse in these groups of mice was our hypothesis that if a more robust skeletal phenotype is a result of greater responsiveness to loading then the degree of bone loss associated with removal of the loading-related stimulus should U0126 ic50 also be greater. Conversely if a less robust skeletal phenotype were to be due to a lower osteogenic responsiveness to loading this should be reflected by a lower level of bone loss associated with disuse. In this experiment a direct comparison between all the genders and genotypes investigated was complicated by basal differences between the WT background of the Lrp5HBM+ and Lrp5−/−

colonies. This may have effects outside and in addition to anything related to loading. It is unknown whether osteoclast activity (which in these almost mature animals would have been responsible for the lower bone mass associated with disuse) is similar in timing or extent in the different groups, even though it has been shown that Lrp5HBM+ and Lrp5−/− mice show no differences in their osteoclast number compared with WT controls [14] and [15]. With these reservations in mind, but assuming that such differences between groups are minor compared with the main effects of their Lrp5 genotype, the outcome of the disuse experiment Phosphoribosylglycinamide formyltransferase appears to be that in cortical bone the degree of bone loss is unaffected by the absence of functional Lrp5. In cancellous bone, absence of a functional Lrp5 receptor is associated with greater disuse-related increase in trabecular spacing and decrease in BV/TV and trabecular number than in WT controls. In contrast the presence of the Lrp5 G171V HBM mutation in the Lrp5HBM+ mice is associated with less loss of cortical and trabecular bone than in their WTHBM− controls. Similar findings on Lrp5HBM+ and Lrp5−/− mice were reported by Bex et al. and Akhter et al. [27] and [28].